Since the dysregulation of neuronal Ca2+ represents an early event in the pathogenesis of models of HD (Zeron et al., 2002; Tang et al., 2003), the HAP1 protein might be considered as a potential therapeutic target in HD. The gene discussed is HAP1; the disease is Huntington disease.